Caresyntax Raises $180 Million Funding to Accelerate Growth and Adoption of Precision Surgery
Healthcare IT Today September 9, 2024
Caresyntax, a vendor-neutral precision surgery platform, is pleased to announce raising a total commitment of $180 million through a series C extension and growth debt expansion round.
Investors in the $180 million round include Symbiotic Capital, MTIP AG, BIONIQ Capital, PFM Health Sciences, Pictet Alternative Advisors, surgical.ai, BlackRock Innovation Capital, Aescuvest, Optum Ventures, Cure Capital, Relyens Group, Vesalius Biocapital, Lauxera Capital, Plug & Play Growth Fund, and ProAssurance Corp. The financing comprises $80M of equity and up to $100M of growth debt facility.
Caresyntax is transforming surgery by implementing a scalable, end-to-end software and AI platform. The platform is medical grade, interoperable, and allows the capture and use of novel data and applications to enhance surgical precision and patient safety....